National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
BAY 43-9006

 A drug used to treat advanced kidney cancer and a type of liver cancer that cannot be removed by surgery. It is also being studied in the treatment of other types of cancer. BAY 43-9006 stops cells from dividing and may prevent the growth of new blood vessels needed for tumors to grow. It is a type of kinase inhibitor and a type of angiogenesis inhibitor. Also called sorafenib, sorafenib tosylate, and Nexavar.

Previous Definitions:baseline, basophil, batimastat, batracylin, BAY 12-9566
Next Definitions:BAY 56-3722, BAY 59-8862, BB-10901, BBBD, BBIC